) has launched the Iconix all suture anchor platform with
IntelliBraid technology at the American Academy of Orthopaedic
Surgeons 2013 Annual Meeting. The device is used in shoulder and
hip arthroscopy surgeries.
The Iconix family of anchors from Stryker's Joint Preservation
business represents the next generation suture anchor technology
with innovative design. Iconix has been around since the first
use of all suture fixation technology in clinical cases in
Stryker acquired this pioneering all suture platform from
Laurane Medical, which it took over in 2011. Since then, the
company has invested in developing the technology to meet the
current operating room needs and allow more flexibility to
Stryker, with a market-cap of $24.65 billion, is one of the
largest medical device manufacturers operating in the global
orthopedic market. The ongoing turnaround in the company's core
Reconstructive business is a major positive for Stryker.
The company's well-diversified product portfolio, expanding
foothold in emerging markets along with acquisitions are expected
to drive future growth. Recently, it completed the acquisition of
China-based Trauson Holdings to grow its market share in the
value-oriented orthopedic segment in developing nations.
Moreover, the company remains committed in delivering
incremental returns to investors, as reflected in the recent hike
in dividend and sizeable share repurchase program.
However, Stryker faces several challenges, which include
continued soft international sales and tough hospital capital
budgets. Despite the recent stability in the domestic market, the
company remains challenged by the prevailing austerity measures
Stryker carries a Zacks Rank #3 (Hold). Companies like
), each carrying a Zacks Rank #2 (Buy), are expected to do well
in the medical industry.
ABAXIS INC (ABAX): Free Stock Analysis Report
EDWARDS LIFESCI (EW): Free Stock Analysis
HANGER ORTHOPED (HGR): Free Stock Analysis
STRYKER CORP (SYK): Free Stock Analysis
To read this article on Zacks.com click here.